Stocks and Investing
Stocks and Investing
Mon, April 12, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Steven Mah Initiated (TWST) at Buy and Held Target at $150 on, Apr 12th, 2021
Steven Mah of Piper Sandler, Initiated "Twist Bioscience Corporation" (TWST) at Buy and Held Target at $150 on, Apr 12th, 2021.
Steven has made no other calls on TWST in the last 4 months.
There are 3 other peers that have a rating on TWST. Out of the 3 peers that are also analyzing TWST, 1 agrees with Steven's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Vijay Kumar of "Evercore ISI Group" Downgraded from Buy to Hold and Increased Target to $140 on, Monday, January 4th, 2021
These are the ratings of the 2 analyists that currently disagree with Steven
- Catherine Schulte of "Baird" Maintained at Buy with Increased Target to $200 on, Friday, February 5th, 2021
- Tycho Peterson of "JP Morgan" Downgraded from Hold to Sell and Held Target at $100 on, Friday, February 5th, 2021
Contributing Sources